Investor Relations

Company Management

ChemoTech is a Swedish public limited liability company. The Company was established in Sweden. The present Company’s date of registration with the Swedish Companies Registration Office is 25 February 2015, and the Company has been in operation since then. The Company complies with the regulations of the Swedish Companies Act (2005:551) and other applicable statutory regulations. The Company is domiciled in Malmö, Sweden.

The basis for the Company’s activities is its Articles of Association. In accordance with Article 3 of the Articles of Association, the Company conducts development, production and marketing of medicotechnical equipment, and related activities. The Company’s Annual General Meeting adopts the Articles of Association and annually appoints the Board of Directors. The Board of Directors is responsible for the organisation and management of the Company, and the appointment or dismissal of the CEO. The Board of Directors annually lays down written procedures for its work, combined with CEO instructions for the division of work between the Board of Directors and the CEO. Matters concerning remuneration or auditing are decided directly by the Company’s Board of Directors. All members of the Board of Directors are elected for a term up to the next Annual General Meeting. Each member of the Board of Directors is entitled to resign at any time.

Investor Relations Contact

Certified Advisor

The Company’s Certified Adviser is Västra Hamnen Corporate Finance. The Certified Adviser continuously assists and reviews the company to ensure that it complies with the Nasdaq First North rules and regulations.

Born 1945. Member of the Board of Directors since 2015. Education and experience: MSc (business and economics), Lund, 1970. Formerly Chairman and CEO of Arjo AB, vice CEO, Tarkett, and head of department, Malmros International. Current assignments: – Previous assignments (last five years): –

Arne Bojesson

CFO

Arne Bojesson is MSc in Business Administration from the Stockholm School of Economics. He has many years of experience from various management positions, among others in listed medical device companies such as Althin Medical and Phase Holographic Imaging. He has also worked in investment banking. He started his career in the Electrolux Group.

Born 1954. Member of the Board of Directors since 2018. Education and experience: University degree in Economics and Marketing. Leg. Midwife and Nurse. Extensive experience from marketing & sales and business development. Business responsibility as Head of Urology Global Marketing at Ferring Pharmaceuticals and commercial roles for AstraZeneca. Current assignments: Board member of LIDDS Pharmaceuticals,…

Born 1979. Product and R&D Director since 2017. Currently on maternity leave. Education and experience: BS Biomedical chemistry. Has a wide experience of life science through her previous experience at companies as Baxter, Gambro and Semcon. Maria has worked with product development, clinical trials, regulatory questions and has experience of electroporation from previous work within biotech.…

Martin Jerndal

Member of the Board of Directors

Born 1975. Member of the Board of Directors since 2015. Education and experience: MSc, Business and Economics (1995-2000). Has extensive banking and financial experience from e.g. Nordea. Current assignments: Execution Trader, Fixed Income, Robur Fonder Previous assignments: Chief Dealer, Head of Credit Trading Sweden, Nordea Markets.

Mohan Frick

CEO and Founder

Born 1974. Member of the Board of Directors and CEO since 2015. Education and experience: BA, Marketing, Management, Lund University. 20 years’ experience as market manager, sales manager and Board member of life science companies. Has among other things held positions in Arjo AB, Getinge, Navigator Communications, Insulution AB, OnMeD and SYSMEX. Current assignments: Chairman of Scandinavian…